VOM Forte Regulatory Status: A Professional Overview for Clinics

VOM Forte is a hyaluronic acid (HA) dermal filler developed and manufactured by CG Bio, a South Korean company recognized in the medical aesthetics sector. As an HA filler, VOM Forte is intended for professional use in aesthetic procedures. When sourcing products like VOM Forte, clinic owners and practitioners prioritize product integrity and compliance.

Professionals seeking to stock high-quality HA fillers should review comprehensive catalogs, which often include VOM Forte and comparable products. For example, our Hyaluronic acid dermal filler catalog provides an extensive selection. Current market data suggests an illustrative wholesale price point for VOM Forte around $67.4 per unit, with volume-based tiered discounts commencing at 11 units (4% off) and extending up to 8% off for orders of 51 units or more.

As a product originating from South Korea, VOM Forte is expected to hold approvals from the Korean Ministry of Food and Drug Safety (KFDA). This national certification confirms that the product meets specific safety and quality standards for sale within its home market. KFDA approval serves as a foundational regulatory benchmark.

Beyond national approval, manufacturing quality is often validated by Good Manufacturing Practice (GMP) certifications. GMP ensures that products are consistently produced and controlled according to quality standards. Additionally, ISO (International Organization for Standardization) certifications, such as ISO 13485 for medical devices, indicate adherence to global quality management systems. [VERIFY: CG Bio's specific GMP and ISO certifications for VOM Forte].

For broader international distribution, specific market-entry certifications are often required. The CE Mark is a critical designation for products sold within the European Economic Area (EEA), indicating conformity with EU health, safety, and environmental protection standards. [VERIFY: VOM Forte's current CE Mark status for the European market]. Without a valid CE Mark, VOM Forte cannot be legally distributed and sold within the EU.

In the United States, regulatory oversight falls under the Food and Drug Administration (FDA). Many aesthetic products developed outside the US do not possess specific FDA approval for direct import and commercial sale within the country. [VERIFY: VOM Forte's current FDA approval status for the US market]. Clinics operating in the US must ensure that any product sourced complies with local FDA regulations.

The legal status of VOM Forte varies significantly across global markets, primarily dependent on local regulatory body approvals. In the EU and UK, the product's legal standing hinges on its CE Mark status, with the UK's MHRA generally aligning with EU standards post-Brexit. However, specific national registrations may still be required.

For the GCC (Gulf Cooperation Council) region, countries like the UAE (MOHAP) and Saudi Arabia (SFDA) mandate their own specific product registrations. Similar requirements exist across LATAM (Latin America), with agencies such as ANVISA in Brazil or COFEPRIS in Mexico overseeing medical device imports. Across APAC (Asia-Pacific), while KFDA approval is a strong foundation, local health authorities in countries like Singapore, Australia, or Japan will have their own distinct approval processes. Sourcing other reputable HA fillers such as UNIONFILL also requires careful attention to these region-specific regulations.

Parallel importing involves sourcing products from outside official distribution channels, often to secure a lower price. While sometimes legal, it introduces substantial risks for aesthetic professionals. These risks include compromised cold chain integrity, difficulty verifying product authenticity, and potential issues with traceability of lot numbers.

Authentic sourcing guarantees that products like VOM Forte are procured through authorized distributors directly from the manufacturer, CG Bio. This channel ensures product quality, efficacy, and safety remain consistent. Professionals should review resources like How to Verify Genuine Dysport 500 Units for Professional Use to understand best practices in verifying product legitimacy across their inventory.

To ensure regulatory compliance and product authenticity for VOM Forte, aesthetic clinics must establish clear requirements for their suppliers. Essential documentation includes the manufacturer’s Certificate of Authenticity for each batch, confirming original production and lot traceability. A Certificate of Analysis (COA) provides details on product specifications and quality control testing.

Further crucial evidence includes proper customs clearance documentation and verification of cold chain management during shipping, especially for temperature-sensitive products. Requesting a distributor authorization letter from CG Bio further solidifies the legitimacy of the supply chain. This due diligence applies to all professional aesthetic injectables, including products discussed in Medam Dermal Filler: A Professional Overview for Clinic Sour.